Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Echocardiography parameters for cardiac dyssynchrony had no predictive value in current multicentric prospective studies concerning cardiac resynchronization therapy. Comprehensive echocardiography and new parameters as 2D and 3D strain, as well as 3D echo have been analyzed, but their definite value has not been proven yet.
In patients with severe heart failure, delays in the conduction system can result in asynchronous contraction impairing cardiac function. By implantation of pacemaker systems with three leads located in atrium, right ventricle and coronary sinus, tracing back this deranged contraction closer to the physiological excitation propagation is aimed (cardial resynchronization therapy [CRT]). Despite patient selection according to the guidelines nearly one-third of the patients do not profit, neither clinically nor echocardiographically, from an implanted CRT-device. In addition, recent studies have shown that no reliable prediction may be achieved with the known echocardiographic parameters of dyssynchrony, regarding the response to such therapy. The aim of this study is therefore to assess new echocardiographic parameters, which may allow to better predict CRT response.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| 3D echocardiography | offline analysis of echocardiography data | 12 months |
| 2D strain | offline analysis of echocardiography data | 12 months |
| m-mode echocardiography | offline analysis of echocardiography data | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| NYHA | New York Heart Association (NYHA) functional classification | 12 months |
| six-min walk test | distance walked over 6 minutes as a sub-maximal test of aerobic capacity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All consecutive patients referred to the University Hospital of Heidelberg with congestive heart failure to undergo the implantation of CRT device
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mathias Konstandin, M.D. | Heidelberg University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Cardiology, University of Heidelberg | Heidelberg | Baden-Wurttemberg | 69120 | Germany |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months |
| NT-proBNP | N-terminal prohormone of brain natriuretic peptide (NT-proBNP) | 12 months |
| LV EF | left ventricular (LV) ejection fraction (EF) | 12 month |